Therefore, we made a hypothesis that the risk base T of MLH1-rs1540354 might promote HBV infection and HCC by enhancing the expression of LRRFIP2 and inhibiting the anti-inflammatory function of NLRP3. The gene discussed is LRRFIP2; the disease is hepatocellular carcinoma.